These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 28471)

  • 1. The pharmacological classification of practolol and chloropractolol.
    Kenakin TP; Black JW
    Mol Pharmacol; 1978 Jul; 14(4):607-23. PubMed ID: 28471
    [No Abstract]   [Full Text] [Related]  

  • 2. Can chloropractolol alkylate beta adrenoceptors?
    Kenakin TP; Black JW
    Nature; 1977 Jan; 265(5592):365-6. PubMed ID: 13308
    [No Abstract]   [Full Text] [Related]  

  • 3. Catechol-O-methyltransferase: substrate-specificity and stereoselectivity for beta-adrenoceptor agents.
    Raxworthy MJ; Youde IR; Gulliver PA
    Xenobiotica; 1986 Jan; 16(1):47-52. PubMed ID: 2868577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential probe for isolation of the beta-adrenoceptor, chloropractolol.
    Erez M; Weinstock M; Cohen S; Shtacher G
    Nature; 1975 Jun; 255(5510):635-6. PubMed ID: 237237
    [No Abstract]   [Full Text] [Related]  

  • 5. Disposition in rats and mice of chloropractolol, a new beta-blocking agent.
    Godeneche D; Pilichowski JF; Meyniel G
    Xenobiotica; 1980 Sep; 10(9):725-33. PubMed ID: 6108651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bivalent ligand type beta-adrenolytics related to practolol.
    Rampa A; Da Re P; Valenti P; Frigeni V; Sala R; Della Bella D
    Drugs Exp Clin Res; 1988; 14(9):581-6. PubMed ID: 2906585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Change of the reactibility of the myocardium following the termination of the beta-blocking effect of trimepranol and practolol].
    Svec P; Inczinger F; Béderová E; Zigová L
    Cesk Farm; 1977 May; 26(4):128-30. PubMed ID: 880637
    [No Abstract]   [Full Text] [Related]  

  • 8. Impairment of the extraneuronal O-methylating system of isoproterenol by stop-flow ischemia in the perfused rat heart.
    Inoue M; Hifumi K; Kurahashi K; Fujiwara M
    J Pharmacol Exp Ther; 1987 Sep; 242(3):1086-9. PubMed ID: 3656108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. cAMP activity and isoproterenol-induced myocardial injury in rats.
    Bhagat B; Sullivan JM; Fischer VW; Nadel EM; Dhalla NS
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 12():465-70. PubMed ID: 202000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The O-methylation of extraneuronally stored isoprenaline in the perfused heart.
    Uhlig W; Bönisch H; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(3):245-61. PubMed ID: 4276755
    [No Abstract]   [Full Text] [Related]  

  • 11. The efficacy of practolol-induced beta1 adrenergic blockade in the canine heart.
    Hoskins EJ; Priola DV; Weiss GK
    Res Commun Chem Pathol Pharmacol; 1978 Jul; 21(1):165-8. PubMed ID: 684274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies on the cardiac activity of prenalterol with reference to use in congestive heart failure.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1982 Jan; 220(1):77-85. PubMed ID: 6118432
    [No Abstract]   [Full Text] [Related]  

  • 13. Analysis of the compartments involved in the extraneuronal storage and metabolism of isoprenaline in the perfused heart.
    Bönisch H; Uhlig W; Trendelenburg U
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 283(3):223-44. PubMed ID: 4276754
    [No Abstract]   [Full Text] [Related]  

  • 14. [The effect of practolol and atenolol on the lysosomal enzyme activity of the ventricular myocardium of rats].
    Sergeev PV; Sysoliatina NA
    Biull Eksp Biol Med; 1991 Nov; 112(11):490-2. PubMed ID: 1667275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experimental findings on tyramine-dependent release of noradrenaline in various parts of the heart under the influence of practolol].
    Brisse B; Bender F
    Z Kardiol; 1975 Oct; 64(10):941-4. PubMed ID: 56095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proceedings: Influence of propranolol and practolol on the turnover of noradrenaline in the rat heart.
    Lemmer B; Saller R
    Naunyn Schmiedebergs Arch Pharmacol; 1974; 282(Suppl):suppl 282:R57. PubMed ID: 4276602
    [No Abstract]   [Full Text] [Related]  

  • 17. Relative efficacy of prenalterol and pirbuterol for beta-1 adrenoceptors: measurement of agonist affinity by alteration of receptor number.
    Kenakin TP; Beek D
    J Pharmacol Exp Ther; 1984 May; 229(2):340-5. PubMed ID: 6143816
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A sensitive radioenzymatic assay for catechol drugs.
    Durrett LR; Ziegler MG
    J Neurosci Res; 1980; 5(6):587-98. PubMed ID: 7205995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic sympathomimetic activity of the partial agonist prenalterol in relation to beta adrenoceptor interaction in various tissues, in vitro.
    Mattsson H; Hedberg A; Carlsson E
    J Pharmacol Exp Ther; 1983 Mar; 224(3):654-61. PubMed ID: 6131123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and binding to beta-adrenergic receptors of p-aminobenzyl analogues of practolol and atenolol.
    Jones GS; Bylund DB; Hanson RN
    J Pharm Sci; 1992 Apr; 81(4):397-8. PubMed ID: 1354250
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.